Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Adicet Bio, Inc. ACET |
RA Capital Management, L.P. | 8,308,532 9.990% |
611,583![]() (+7.95%) |
Filing History |
2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Alto Neuroscience, Inc. ANRO |
RA Capital Management, L.P. | 2,075,154 7.700% |
689,663![]() (+49.78%) |
Filing History |
2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Avidity Biosciences, Inc. RNA |
RA Capital Management, L.P. | 6,300,408 5.400% |
1,404,449![]() (+28.69%) |
Filing History |
2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | GH Research PLC GHRS |
RA Capital Management, L.P. | 6,686,689 12.900% |
1,099,356![]() (+19.68%) |
Filing History |
2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Enliven Therapeutics, Inc. ELVN |
RA Capital Management, L.P. | 1,061,233 2.200% |
1,061,233![]() (New Position) |
Filing History |
2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
RA Capital Management, L.P. | 6,084,412 9.950% |
754,000![]() (+14.15%) |
Filing History |
2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Vaxcyte, Inc. PCVX |
RA Capital Management, L.P. | 12,649,728 9.990% |
2,964,649![]() (+30.61%) |
Filing History |
2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Verona Pharma plc VRNA |
RA Capital Management, L.P. | 8,460,090 9.990% |
956,114![]() (+12.74%) |
Filing History |
2024-11-13 6:04 pm Purchase |
2024-11-08 | 13D | Tyra Biosciences, Inc. TYRA |
RA Capital Management, L.P. | 10,677,140 21.100% |
586,069![]() (+5.81%) |
Filing History |
2024-11-12 4:15 pm Purchase |
2024-11-04 | 13G | Bright Minds Biosciences Inc. DRUG |
RA Capital Management, L.P. | 460,829 6.600% |
460,829![]() (New Position) |
Filing History |
2024-11-06 5:41 pm Purchase |
2024-10-30 | 13G | GlycoMimetics, Inc. GLYC |
RA Capital Management, L.P. | 6,383,000 9.900% |
6,383,000![]() (New Position) |
Filing History |
2024-11-06 4:15 pm Purchase |
2024-10-30 | 13G | Ensysce Biosciences, Inc. ENSC |
RA Capital Management, L.P. | 98,400 9.900% |
98,400![]() (New Position) |
Filing History |
2024-11-05 4:17 pm Purchase |
2024-10-29 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
RA Capital Management, L.P. | 3,566,338 6.100% |
3,566,338![]() (New Position) |
Filing History |
2024-11-04 4:39 pm Purchase |
2024-10-28 | 13D | Septerna, Inc. SEPN |
RA Capital Management, L.P. | 6,995,858 15.800% |
6,995,858![]() (New Position) |
Filing History |
2024-10-31 4:17 pm Purchase |
2024-10-24 | 13G | Monopar Therapeutics Inc. MNPR |
RA Capital Management, L.P. | 511,207 9.700% |
511,207![]() (New Position) |
Filing History |
2024-10-22 5:11 pm Sale |
2024-10-18 | 13D | Tyra Biosciences, Inc. TYRA |
RA Capital Management, L.P. | 10,091,071 19.990% |
-384,418![]() (-3.67%) |
Filing History |
2024-10-22 4:17 pm Sale |
2024-10-18 | 13D | Janux Therapeutics, Inc. JANX |
RA Capital Management, L.P. | 10,443,181 19.990% |
-299,812![]() (-2.79%) |
Filing History |
2024-10-07 4:16 pm Purchase |
2024-09-27 | 13G | BioAge Labs, Inc. BIOA |
RA Capital Management, L.P. | 2,210,589 6.200% |
2,210,589![]() (New Position) |
Filing History |
2024-10-01 5:47 pm Purchase |
2024-09-27 | 13D | Wave Life Sciences Ltd. WVE |
RA Capital Management, L.P. | 25,414,165 16.000% |
8,144,354![]() (+47.16%) |
Filing History |
2024-09-23 4:17 pm Purchase |
2024-09-16 | 13D | Bicara Therapeutics Inc. Common Stock BCAX |
RA Capital Management, L.P. | 6,955,993 12.800% |
6,955,993![]() (New Position) |
Filing History |